KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
South Korea · Delayed Price · Currency is KRW 698.00
+16.00 (2.35%)
At close: Sep 14, 2026
KMPHARMACEUTICAL Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 138.4 | 350.62 | 221.05 | 953.37 | 447.75 | 2,131 |
Short-Term Investments | - | - | - | 70.5 | 150 | 235 |
Trading Asset Securities | - | - | 588.92 | - | - | 330.1 |
Cash & Short-Term Investments | 138.4 | 350.62 | 809.97 | 1,024 | 597.75 | 2,697 |
Cash Growth | 232.69% | -56.71% | -20.89% | 71.29% | -77.83% | -54.13% |
Accounts Receivable | 1,838 | 1,170 | 1,235 | 1,594 | 2,260 | 3,577 |
Other Receivables | 92.27 | 45.45 | 85.26 | 739.44 | 14.15 | 175.58 |
Receivables | 1,930 | 1,216 | 1,321 | 2,333 | 2,274 | 3,753 |
Inventory | 2,134 | 2,018 | 2,424 | 2,385 | 2,453 | 2,759 |
Prepaid Expenses | 158.45 | 154.09 | 140.81 | 202.27 | 256.78 | 591.69 |
Other Current Assets | 13.93 | 31.23 | 21.55 | 37.19 | 763.4 | 45.81 |
Total Current Assets | 4,374 | 3,770 | 4,717 | 5,982 | 6,345 | 9,846 |
Property, Plant & Equipment | 21,517 | 20,415 | 21,096 | 21,183 | 22,325 | 25,009 |
Long-Term Investments | 6,724 | 6,756 | 7,417 | 5,503 | 4,648 | 4,202 |
Other Intangible Assets | 17.83 | 20.21 | 14.24 | 29.41 | 67.68 | 105.7 |
Long-Term Accounts Receivable | 60.36 | 60.36 | - | - | - | - |
Long-Term Deferred Tax Assets | - | - | - | 775.7 | 1,258 | 720.28 |
Other Long-Term Assets | 6,927 | 7,227 | 7,305 | 8,220 | 8,307 | 7,794 |
Total Assets | 47,713 | 46,393 | 48,973 | 50,555 | 51,281 | 52,676 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,197 | 1,249 | 998.73 | 802.07 | 636.39 | 1,269 |
Accrued Expenses | 843.09 | 827.95 | 856.86 | 1,275 | 603.13 | 898.07 |
Short-Term Debt | 6,500 | 4,800 | 4,000 | 6,000 | 2,500 | 1,000 |
Current Portion of Long-Term Debt | 7,000 | 4,833 | 3,136 | 3,272 | 8,272 | 3,367 |
Current Portion of Leases | - | - | - | 39.08 | 51.69 | 51.69 |
Current Income Taxes Payable | - | - | - | - | - | 26.12 |
Current Unearned Revenue | 7.23 | 14.62 | 14.62 | 0.58 | 12.57 | 32.51 |
Other Current Liabilities | 276.45 | 173.74 | 309.97 | 493.55 | 422.68 | 828.16 |
Total Current Liabilities | 15,824 | 11,898 | 9,316 | 11,882 | 12,498 | 7,473 |
Long-Term Debt | 5,170 | 6,167 | 7,000 | 3,136 | 2,408 | 5,180 |
Long-Term Leases | - | - | - | - | 36.58 | 82.62 |
Other Long-Term Liabilities | 48.34 | 61.84 | 41.94 | 59.08 | 10.15 | 34.32 |
Total Liabilities | 21,043 | 18,127 | 16,358 | 15,077 | 14,953 | 12,770 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2,789 | 2,789 | 2,789 | 2,789 | 2,789 | 2,789 |
Additional Paid-In Capital | 10,911 | 10,911 | 42,562 | 42,562 | 42,562 | 42,562 |
Retained Earnings | 12,058 | 13,648 | -14,035 | -9,462 | -8,142 | -4,217 |
Treasury Stock | -5.62 | -0.17 | -0.17 | -0.17 | -0.17 | -0.17 |
Comprehensive Income & Other | 918.59 | 918.59 | 1,299 | -410.63 | -881.32 | -1,228 |
Shareholders' Equity | 26,670 | 28,266 | 32,615 | 35,479 | 36,328 | 39,906 |
Total Liabilities & Equity | 47,713 | 46,393 | 48,973 | 50,555 | 51,281 | 52,676 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 18,670 | 15,800 | 14,136 | 12,447 | 13,268 | 9,681 |
Net Cash (Debt) | -18,532 | -15,449 | -13,326 | -11,423 | -12,671 | -6,985 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -664.44 | -554.00 | -477.87 | -406.72 | -455.17 | -251.42 |
Filing Date Shares Outstanding | 5.58 | 5.58 | 5.58 | 5.58 | 5.58 | 5.58 |
Total Common Shares Outstanding | 5.58 | 5.58 | 5.58 | 5.58 | 5.58 | 5.58 |
Working Capital | -11,450 | -8,128 | -4,599 | -5,900 | -6,153 | 2,373 |
Book Value Per Share | 4783.82 | 5068.02 | 5847.72 | 6361.13 | 6513.42 | 7154.97 |
Tangible Book Value | 26,652 | 28,246 | 32,601 | 35,449 | 36,260 | 39,800 |
Tangible Book Value Per Share | 4780.62 | 5064.40 | 5845.17 | 6355.86 | 6501.28 | 7136.02 |
Land | 13,792 | 13,707 | 13,707 | 12,985 | 12,985 | 13,045 |
Buildings | 6,884 | 6,516 | 6,516 | 6,374 | 6,374 | 6,886 |
Machinery | 9,081 | 6,339 | 6,013 | 5,883 | 5,936 | 6,736 |
Construction In Progress | 1,175 | 5.05 | 96.25 | 15.28 | 11.53 | 12.52 |